Table 2.
Correlation coefficients between the staging systems vs. the PFT parameters (FVC and DLCO at baseline and after 12 months of treatment)
| Staging systems | FVC (baseline) | FVC (absolute change) | DLCO (baseline) | DLCO (absolute change) | ||||
|---|---|---|---|---|---|---|---|---|
| Placebo | CYC | Placebo | CYC | Placebo | CYC | Placebo | CYC | |
| MaxFib | −0.21 (0.15) | −0.16 (0.29) | −0.31 (0.88) | 0.34 (0.02) | −0.46 (0.001) | −0.44 (0.003) | −0.02 (0.88) | 0.13 (0.41) |
| Goh and Wells unadjusted stratification | −0.05 (0.75) | −0.25 (0.09) | −0.21 (0.15) | 0.10 (0.50) | −0.48 (0.001) | −0.51 (0.001) | 0.003 (0.98) | 0.17 (0.27) |
| QILD WL | −0.38 (0.008) | −0.08 (0.61) | −0.23 (0.12) | 0.41 (0.006) | −0.35 (0.01) | −0.07 (0.63) | −0.35 (0.02) | 0.12 (0.45) |
| QILD ZM | −0.27 (0.07) | −0.19 (0.23) | −0.20 (0.17) | 0.40 (0.008) | −0.41 (0.005) | −0.24 (0.12) | −0.30 (0.04) | 0.25 (0.10) |
| QLF WL | −0.17 (0.26) | −0.25 (0.11) | −0.22 (0.13) | 0.06 (0.62) | −0.22 (0.13) | −0.20 (0.20) | −0.10 (0.50) | 0.16 (0.32) |
| QLF ZM | −0.45 (0.002) | −0.39 (0.02) | −0.15 (0.31) | 0.18 (0.23) | −0.43 (0.002) | −0.41 (0.005) | −0.22 (0.13) | 0.12 (0.45) |
FVC forced vital capacity, MaxFib visual maximum fibrosis score, QILD WL quantitative assessment of total extent of interstitial lung disease in whole lung, QILD ZM quantitative assessment of total extent of interstitial lung disease in zone of maximal involvement, QLF WL quantitative percentage with fibrosis in whole lung, QLF ZM quantitative percentage with fibrosis in zone of maximal involvement, CYC cyclophosphamide, DLCO diffusing capacity for carbon monoxide
The values are Pearson’s correlation coefficients; p values are presented in parentheses